Asper also launched an array for Wilson disease screening that assays 104 mutations in the ATP7B gene. The Wilson disease chip was developed and validated with the University of Brno in the Czech Republic, Asper said.
Jul 08, 2008
Asper Biotech launched two arrays this month. The first is a chip for screening six genes connected with hereditary breast and ovarian cancer.
The company said the array enables users to analyze 88 mutations in the BRCA1, BRCA2, CHEK2, RAD51, NBN, and CASP8 genes.